Shandong, China

Jingjing Yin

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Suzhou Vigonvita Life Sciences Co., Ltd., Topharman Shandong Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jingjing Yin. Retrieved from https://idiyas.com/inventor/jingjing-yin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jingjing Yin in Heterocyclic Compounds

Introduction

Jingjing Yin is a notable inventor based in Shandong, China. She has made significant contributions to the field of medicinal chemistry, particularly in the development of heterocyclic compounds. Her work focuses on creating compounds that can be used in the prevention and treatment of central nervous system diseases.

Latest Patents

Jingjing Yin holds a patent for a heterocyclic compound, which is represented by a specific formula. This invention includes its stereoisomers and pharmaceutically acceptable salts. The patent also covers pharmaceutical compositions derived from these compounds and their applications in preparing medicaments for central nervous system diseases.

Career Highlights

Throughout her career, Jingjing has worked with prestigious institutions such as the Chinese Academy of Sciences and Suzhou Vigonvita Life Sciences Co., Ltd. Her experience in these organizations has allowed her to advance her research and contribute to the scientific community.

Collaborations

Jingjing has collaborated with esteemed colleagues, including Hualiang Jiang and Zhen Wang. These partnerships have enhanced her research efforts and fostered innovation in her field.

Conclusion

Jingjing Yin's work in the development of heterocyclic compounds showcases her dedication to advancing medical science. Her contributions are vital for the ongoing research in treating central nervous system diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…